Literature DB >> 1475789

The effect of carnitine on the metabolism of valproic acid in epileptic patients.

K Sakemi1, K Hayasaka, M Tahara, Y Sanada, G Takada.   

Abstract

The half-life of valproic acid (VPA) was studied in 8 epileptic and severely mental retarded patients before and after one month of carnitine supplementation. Serum carnitine concentration was significantly decreased and VPA half-life was prolonged especially in adult patients before carnitine supplementation. After the treatment with carnitine, serum carnitine concentration was increased, and prolonged half-lives of VPA were corrected near to the normal range (from 12.2 +/- 4.2 hr to 9.7 +/- 2.2 hr; p < 0.05). Controlled state of epilepsy was unchanged during the short period of observation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1475789     DOI: 10.1620/tjem.167.89

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  1 in total

1.  Serum free carnitine levels during valproic acid therapy.

Authors:  S Tütüncüoglu; H Tekgül; E Levent; A Hüseyinov
Journal:  Indian J Pediatr       Date:  1997 Jul-Aug       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.